SCHEMBL24496280

SCHEMBL24496280

CNS(=O)(=O)c1ccc(Nc2ccc(C(F)(F)F)cn2)c(-c2cn(CCO)cn2)c1

nearest known ligand 0.59

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 2/20 0.59
▸ YAP1 P46937 1/20 0.59
▸ TNNI3K Q59H18 6/20 0.47
▸ MAPT P10636 1/20 0.44
▸ BRAF P15056 5/20 0.43
▸ TLR2 O60603 4/20 0.41
▸ TLR1 Q15399 4/20 0.41
▸ KDM4E B2RXH2 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ JAK1 P23458 1/20 0.35
▸ TYK2 P29597 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24496353 0.88 TEAD1 (0.57) TEAD1YAP1TNNI3KMAPTBRAF
SCHEMBL29438880 0.87 TEAD1 (0.77) TEAD1YAP1TNNI3KMAPTBRAF
SCHEMBL22718190 0.87 TEAD1 (0.77) TEAD1YAP1TNNI3KMAPTBRAF
SCHEMBL22718126 0.86 TEAD1 (0.55) TEAD1YAP1TNNI3KMAPTBRAF
SCHEMBL22718107 0.84 TEAD1 (0.53) TEAD1YAP1TNNI3KMAPTBRAF
SCHEMBL29438867 0.84 TEAD1 (0.53) TEAD1YAP1TNNI3KMAPTBRAF
SCHEMBL22718252 0.83 TEAD1 (0.59) TEAD1YAP1TNNI3KMAPTBRAF
SCHEMBL29704149 0.82 TNNI3K (0.47) TEAD1YAP1TNNI3KMAPTTLR2
SCHEMBL22718131 0.81 TEAD1 (0.58) TEAD1YAP1TNNI3KMAPTBRAF
SCHEMBL24496050 0.81 TEAD1 (0.39) TEAD1YAP1MAPTTLR2TLR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022120353-A1 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
WO-2022120355-A1 TEAD DEGRADERS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
WO-2022120353-A1 TEAD INHIBITORS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
WO-2022120355-A1 TEAD DEGRADERS AND USES THEREOF Ikena Oncology, Inc. (US) 2022-06-09 — — WO disclosed
Send feedback